Canakinumab Subcutaneous and ProCentra
Determining the interaction of Canakinumab Subcutaneous and ProCentra and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dextroamphetamine
Brand name: Dexedrine Spansule, ProCentra, Zenzedi, Dexedrine, Dextrostat, Liquadd
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Prochieve
- Canakinumab Subcutaneous-Prochieve (Progesterone Vaginal 4% Gel)
- Canakinumab Subcutaneous-Prochieve (Progesterone Vaginal 8% Gel)
- Canakinumab Subcutaneous-Prochlorperazine
- Canakinumab Subcutaneous-Prochlorperazine Edisylate
- Canakinumab Subcutaneous-Prochlorperazine Injection
- ProCentra-Canasa
- ProCentra-Canasa Pac rectal
- ProCentra-Canasa rectal
- ProCentra-Cancidas
- ProCentra-Candesartan
- ProCentra-Candesartan and Hydrochlorothiazide